Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

NCT00069849 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00069849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00069849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2003
Completion date
Not reported
Enrollment
64
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease